Stock listing

NASDAQ:HPTX Hyperion Therapeutics Inc Stock

Follow Hyperion Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:HPTX

$45.99 USD

Close on May 7, 2015 · No longer trades

Jul 26, 2012 to last close +354.9% · weekly closes, Jul 26, 2012 – May 7, 2015
Lowest – highest close
$10.04 – $46.14 USDSince Jul 26, 2012 · lowest Aug 17, 2012 · highest Apr 21, 2015

Delisted NASDAQ:HPTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:HPTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Daniel G. Welch
Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); AveXis Inc (Director · Feb 10, 2016 – May 15, 2018 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – May 28, 2020 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Seagen Inc (Director · Jun 13, 2007 – Dec 14, 2023 · Past); InterMune Inc (Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past)
Director · Aug 23, 2012 – May 7, 2015 · Past
Lota S Zoth
Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); enGene Therapeutics Inc. (Director · Since at least Dec 18, 2023); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Lumos Pharma Inc (Director · Nov 2, 2012 – Dec 12, 2024 · Past); Orexigen Therapeutics Inc (Director · Apr 26, 2012 – Jul 14, 2017 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past)
Director · Jul 25, 2012 – May 7, 2015 · Past
Theodore R Schroeder
Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Apr 16, 2025); Cidara Therapeutics Inc (Director · Since at least Apr 14, 2015); Nabriva Therapeutics AG (Director · Jul 24, 2018 – Jan 29, 2023 · Past); Collegium Pharmaceutical, Inc. (Director · Jan 22, 2016 – May 20, 2020 · Past); Otonomy Inc (Director · Aug 28, 2015 – Jun 21, 2022 · Past); Trius Therapeutics Inc (Director · Aug 2, 2010 – Sep 11, 2013 · Past); Cadence Pharmaceuticals Inc (President, CEO, Director · Oct 24, 2006 – Mar 19, 2014 · Past)
Director · Aug 11, 2014 – May 7, 2015 · Past
Jeffrey Farrow
Other companies: Achieve Life Sciences, Inc. (Director · Since at least May 29, 2026); Tarsus Pharmaceuticals, Inc. (See Remarks · Since at least Apr 24, 2023); Lisata Therapeutics, Inc. (Director · Since Oct 13, 2026 · Appointed, no departure found); Global Blood Therapeutics Inc (Chief Financial Officer · Apr 4, 2016 – Oct 5, 2022 · Past); ZS Pharma Inc (Chief Financial Officer · Jul 8, 2015 – Dec 17, 2015 · Past); Renovis Inc (V.P., Finance and CAO · Jul 1, 2007 – May 2, 2008 · Past)
CFO · Jul 25, 2012 – May 7, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Hyperion Therapeutics Inc.